Prime Medicine, Inc
Prime Medicine, Inc is a Healthcare & Life Sciences startup based in Cambridge, Massachusetts, the United States, most recent round Series A, 1 tracked investor.
About Prime Medicine, Inc
Prime Medicine, Inc is a company headquartered in Cambridge, Massachusetts, the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Prime Medicine develops one-time gene editing therapies based on its Prime Editing technology, which edits disease-causing DNA sequences at their precise location in the genome. The company is pursuing clinical programs, including a Wilson disease trial and an alpha-1 antitrypsin deficiency candidate.
Explore Prime Medicine, Inc's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.